(Press-News.org) LA JOLLA, CA -- October 9, 2013 -- A team led by scientists at The Scripps Research Institute (TSRI) has identified key signaling proteins in the inflammation process that contribute to the development of inflammatory diseases such as rheumatoid arthritis, psoriasis, sepsis and inflammatory bowel diseases. The finding highlights possible new ways of treating these inflammation disorders, which sicken or kill millions of people around the world each year.
"We hope our approach will lead to the development of drugs that augment current anti-inflammatory strategies," said TSRI Assistant Professor Young Jun Kang, who was the principal investigator for the new study, which was reported recently in the journal Science Signaling.
The inflammatory signaling pathway in question is an ancient one that can be found in a range of evolutionarily disparate species, from fruit flies to humans. Working as a primary defense system against bacteria and other intruders, it is triggered by a special set of receptors on white blood cells called Toll-like receptors (TLRs), which recognize molecular patterns associated with common microbes.
When they have detected a foe in this way, TLRs switch on the production, within their host cells, of a variety of inflammatory and anti-microbial compounds. These include the inflammatory protein TNF-α (tumor necrosis factor alpha), a cause of fever and malaise in systemic infections, and also a contributor -- when produced for too long -- to inflammatory disorders such as rheumatoid arthritis, psoriasis and inflammatory bowel disease.
TNF-α also features heavily in the condition called sepsis, a runaway process of inflammation in the bloodstream that can end up damaging vital organs, lowering blood pressure to life-threatening levels (septic shock) and causing blood to coagulate within vessels throughout the body. Sepsis as a result of bacterial infection kills a quarter of a million people in the U.S. each year.
As Kang and other investigators have shown, this type of inflammation typically has an early, acute phase and a late, sustained phase, the two phases being driven by distinct clusters of signaling molecules. Ideally, to treat or prevent inflammatory disorders, one would want to suppress the late phase while leaving the early phase intact to fight ordinary infections -- and this has been Kang's aim for most of the past decade. In a study published in 2007 when he was a postdoctoral fellow at TSRI, Kang identified an immune cell protein called 4-1BBL as a critical factor in the late phase of a common type of inflammation triggered by the receptor TLR4.
In the new study, Kang and his colleagues examined 4-1BBL and its signaling partners in more detail to better understand the pathway and to find suitable drug targets.
In a series of experiments with cultured cells, Kang's colleagues Research Associates Jianhui Ma and Bo-Ram Bang were able to show that in late-phase, TLR4-triggered inflammation, 4-1BBL depends heavily on two other key proteins, TIRAP and IRAK2.
TIRAP appeared to be particularly important. Blocking its interaction with 4-1BBL by removing its gene from cells or by applying a specific chemical inhibitor, reduced late-phase inflammation -- as shown by a big drop in TNF-α production. In mice with TLR4-triggered sepsis, inhibiting TIRAP again worked to reduce TNF-α levels and extended the animals' survival.
Kang and his laboratory now plan to test anti-inflammation therapeutic strategies, such as small chemicals and recombinant proteins that target the TIRAP-4-1BBL interaction, with the hope of eventually being able to develop a new class of anti-inflammatory therapy.
As Kang notes, current anti-inflammatory therapies typically aim to reduce TNF-α activity, for example with antibodies, after the protein has already been produced. His strategy has the potential advantage that it targets an earlier part of the process and thereby suppresses TNF-α production -- nipping it in the bud, so to speak.
"We think that this will at least complement the current strategy," Kang said.
INFORMATION:
In addition to Kang, Ma and Bang, contributors to the study, "The Tumor Necrosis Family Member 4-1BBL Sustains Inflammation by Interacting with TLR Signaling Components During Late-Phase Activation," also include Jiawei Lu and Peter Tobias of TSRI; Jiahuai Han of Xiamen University; So-Young Eun and Michael Croft of the La Jolla Institute for Allergy and Immunology; Motoyuki Otsuka of the University of Tokyo; Osamu Takeuchi of Kyoto University; Shizuo Akira of Osaka University; Michael Karin of the University of California, San Diego; and Hideo Yagita of the Juntendo University School of Medicine. For more information on the study, see http://stke.sciencemag.org/cgi/content/abstract/6/295/ra87
The study was funded in part by the National Institutes of Health (AI088229, AI42944 and AI85291).
Scientists find potential new targets for anti-inflammatory therapies
2013-10-10
ELSE PRESS RELEASES FROM THIS DATE:
Gene movements observed in vivo
2013-10-10
This new method will be a great step forwards to understanding the resulting processes that control gene regulation.
These results were published on October 6, 2013 on the website of the review Nature Structural & Molecular Biology.
In the cell nucleus, DNA is highly dynamic and changes its spatial configuration, in the same way as during the process of cell division. We already know that the spatial configuration of DNA determines whether the genes are active or inactive, in other words whether they are capable of expression. In this study, the researchers attempted ...
Correcting emotional misunderstandings
2013-10-10
When we are sad the world seemingly cries with us. On the contrary, when we are happy everything shines and all around people's faces seem to rejoyce with us. These projection mechanisms of one's emotions onto others are well known to scientists, who believe they are at the core of the ability to interpret and relate to others. In some circumstances, however, this may lead to gross mistakes (called egocentricity bias in the emotional domain EEB), to avoid them cerebral mechanisms are activated about which still little is known.
Giorgia Silani, a neuroscientist at SISSA, ...
Weight loss through the use of intestinal barrier sleeves
2013-10-10
Bariatric surgeries, such as a gastric bypass, are currently the most effective anti-obesity therapies. They also lead to a reduced insulin resistance. However, the pitfall of these surgical interventions is that they are highly invasive and often permanent procedures. An international team of scientists led by Dr. Kirk Habegger, Metabolic Disease Institute, University of Cincinnati, and Prof. Dr. Matthias Tschöp, Scientific Director of the Helmholtz Diabetes Center (HDC) at the Helmholtz Zentrum München (HMGU), Partner of the German Center for Diabetes Research (DZD), ...
Malaria, toxoplasmosis: Toward new lines of research?
2013-10-10
This work, published on 10th October on the website of Nature Communications, concerns the role of one protein which is common to these parasites. Called AMA1, it has been at the heart of many years' research on upgrading treatments, such as trying out vaccination against malaria. However, the present authors have reservations about the success of therapeutic strategies which rely solely on the blockage of AMA1, by demonstrating that the malaria and toxoplasmosis parasites, without the protein, can develop normally.
With 1 million victims every year, malaria is the most ...
I'm ok, you're not ok
2013-10-10
This news release is available in German. Egoism and narcissism appear to be on the rise in our society, while empathy is on the decline. And yet, the ability to put ourselves in other people's shoes is extremely important for our coexistence. A research team headed by Tania Singer from the Max Planck Institute for Human Cognitive and Brain Sciences has discovered that our own feelings can distort our capacity for empathy. This emotionally driven egocentricity is recognised and corrected by the brain. When, however, the right supramarginal gyrus doesn't function properly ...
'Ship in a bottle' detects dangerous vapors
2013-10-10
Rice University scientists took a lesson from craftsmen of old to assemble microscopic compounds that warn of the presence of dangerous fumes from solvents.
The researchers combined a common mineral, zeolite, with a metallic compound based on rhenium to make an "artificial nose" that can sniff out solvent gases. They found that in the presence of the compound, each gas had a photoluminescent "fingerprint" with a specific intensity, lifetime and color.
Rice chemist Angel Martí and his students reported their results this month in the journal Angewandte Chemie.
The ...
3D model reveals new information about iconic volcano
2013-10-10
The volcano on the Scottish peninsula Ardnamurchan is a popular place for the study of rocks and structures in the core of a volcano. Geology students read about it in text books and geologists have been certain that the Ardnamurchan volcano have three successive magma chambers. However, an international group of researchers, lead from Uppsala University, Sweden, has now showed that the volcano only has one single magma chamber.
The new study is published in Scientific Reports, the new open access journal of the Nature Publishing Group.
The 58 million year old Ardnamurchan ...
Several top websites use device fingerprinting to secretly track users
2013-10-10
A new study by KU Leuven-iMinds researchers has uncovered that 145 of the Internet's 10,000 top websites track users without their knowledge or consent. The websites use hidden scripts to extract a device fingerprint from users' browsers. Device fingerprinting circumvents legal restrictions imposed on the use of cookies and ignores the Do Not Track HTTP header. The findings suggest that secret tracking is more widespread than previously thought.
Device fingerprinting, also known as browser fingerprinting, is the practice of collecting properties of PCs, smartphones and ...
After almost a century, a question answered; genes protect themselves against being silenced
2013-10-10
Harvard Stem Cell Institute (HSCI) researchers have settled a century-old debate over whether occurrence of DNA methylation acts to silence gene expression, or if genes are turned off by other means before they are methylated.
As explicated today in the journal Nature, methylation in fact enforces gene silencing, and it is levels of a newly identified form of RNA produced by individual genes that determines whether they are turned off by the addition of a methyl (CH3) group by the enzyme DNA methylase 1 (DNMT1).
The study, led by HSCI Principal Faculty member Daniel ...
'Stadium waves' could explain lull in global warming
2013-10-10
One of the most controversial issues emerging from the recent Intergovernmental Panel on Climate Change (IPCC) Fifth Assessment Report (AR5) is the failure of global climate models to predict a hiatus in warming of global surface temperatures since 1998. Several ideas have been put forward to explain this hiatus, including what the IPCC refers to as 'unpredictable climate variability' that is associated with large-scale circulation regimes in the atmosphere and ocean. The most familiar of these regimes is El Niño/La Niña, which are parts of an oscillation in the ocean-atmosphere ...